New Delhi: Drug firm Ipca Laboratories today posted 58.28 per cent rise in its net profit at Rs. 139.12 crore for the third quarter ended December 31, 2013.
The company had posted a net profit of Rs. 87.89 crore in the same period previous fiscal.
Net sales of the company rose to Rs. 815.15 crore during the third quarter this fiscal compared to Rs. 692.41 crore in the same period previous fiscal, Ipca Laboratories said in a filing to the BSE.
Shares of Ipca Laboratories were trading at Rs. 778 apiece on the BSE in late afternoon trade, up 1.25 per cent from their previous close.
The company had posted a net profit of Rs. 87.89 crore in the same period previous fiscal.
Net sales of the company rose to Rs. 815.15 crore during the third quarter this fiscal compared to Rs. 692.41 crore in the same period previous fiscal, Ipca Laboratories said in a filing to the BSE.
Shares of Ipca Laboratories were trading at Rs. 778 apiece on the BSE in late afternoon trade, up 1.25 per cent from their previous close.
0 comments:
Post a Comment